{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:26:25Z","timestamp":1791059185023,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.amjmed.2004.03.032","type":"journal-article","created":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T10:10:39Z","timestamp":1095329439000},"page":"412-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevance"],"prefix":"10.1016","volume":"117","author":[{"given":"Chadwick W.","family":"Christine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Aminoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2004.03.032_bib1","first-page":"S84","article-title":"Errors and delays in diagnosing Parkinson's disease","volume":"52","author":"Reich","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976\u20131990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2004.03.032_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmj.321.7252.21","article-title":"Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London","volume":"321","author":"Schrag","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2004.03.032_bib6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson's disease and parkinsonism in a longitudinal study","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1212\/WNL.42.10.1901","article-title":"Prevalence of Parkinson's disease and other types of parkinsonism","volume":"42","author":"Morgante","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneur.56.1.98","article-title":"Clinical correlates of vascular parkinsonism","volume":"56","author":"Winikates","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2001-13117","article-title":"Multiple system atrophy","volume":"21","author":"Wenning","year":"2001","journal-title":"Semin Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archneur.57.3.369","article-title":"The evolution of diagnosis in early Parkinson disease","volume":"57","author":"Jankovic","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<267::AID-GPS107>3.0.CO;2-7","article-title":"Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies","volume":"15","author":"Walker","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","article-title":"What features improve the accuracy of clinical diagnosis in Parkinson's disease","volume":"42","author":"Hughes","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib14","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.10711","article-title":"Familial Aggregation of early- and late onset Parkinson's disease","volume":"54","author":"Marder","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/jnnp.73.4.363","article-title":"The genetic basis of Parkinson's disease","volume":"73","author":"Foltynie","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.10324","article-title":"A susceptibility gene for late-onset idiopathic Parkinson's disease","volume":"52","author":"Hicks","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson's disease","volume":"2","author":"Gonera","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2004.03.032_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/ana.410440703","article-title":"The natural history of Parkinson's disease","volume":"44","author":"Poewe","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson's disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib22","first-page":"197","article-title":"Magnetic resonance imaging and spectroscopy in Parkinson's disease","volume":"86","author":"Martin","year":"2001","journal-title":"Adv Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","article-title":"Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography","volume":"45","author":"Becker","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s007020200015","article-title":"Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease","volume":"109","author":"Walter","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.amjmed.2004.03.032_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.60.1.74","article-title":"Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes","volume":"60","author":"Walter","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/mds.10214","article-title":"Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease","volume":"17","author":"O'Neill","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2004.03.032_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.410400305","article-title":"Treatment of advanced Parkinson's disease by posterior GPi pallidotomy","volume":"40","author":"Baron","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM199710093371503","article-title":"Posteroventral medial pallidotomy in advanced Parkinson's disease","volume":"337","author":"Lang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.032_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.032_bib30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1212\/WNL.51.3.850","article-title":"Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease","volume":"51","author":"Kumar","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMoa000827","article-title":"Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.032_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/WNL.49.4.1083","article-title":"Preoperative indicators of clinical outcome following stereotaxic pallidotomy","volume":"49","author":"Kazumata","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/WNL.59.6.932","article-title":"Predictors of effective bilateral subthalamic nucleus stimulation for PD","volume":"59","author":"Charles","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00127893-200211000-00006","article-title":"Drug-induced parkinsonism","volume":"8","author":"Van Gerpen","year":"2002","journal-title":"Neurologist"},{"key":"10.1016\/j.amjmed.2004.03.032_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/52.1.23","article-title":"Arteriosclerotic parkinsonism","volume":"52","author":"Critchley","year":"1929","journal-title":"Brain"},{"key":"10.1016\/j.amjmed.2004.03.032_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048607","article-title":"Vascular parkinsonism","volume":"21","author":"Foltynie","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mds.10202","article-title":"Clinical correlates of the pathology underlying parkinsonism","volume":"17","author":"Bower","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2004.03.032_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0404.2001.104002063.x","article-title":"Vascular parkinsonism","volume":"104","author":"Demirkiran","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amjmed.2004.03.032_bib39","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archneur.56.12.1441","article-title":"Dementia associated with Lewy bodies","volume":"56","author":"Weiner","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.53.6.1284","article-title":"Clinical and quantitative pathologic correlates of dementia with Lewy bodies","volume":"53","author":"Gomez-Tortosa","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib41","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","article-title":"Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies","volume":"54","author":"McKeith","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.67.1.66","article-title":"White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging","volume":"67","author":"Barber","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib44","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2004.03.032_bib45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00002018-200225070-00005","article-title":"Benefit-risk considerations in the treatment of dementia with Lewy bodies","volume":"25","author":"Swanberg","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjmed.2004.03.032_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4088\/JCP.v63n0608","article-title":"Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies","volume":"63","author":"Fernandez","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.50.6.1637","article-title":"Progressive supranuclear palsy","volume":"50","author":"Santacruz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/120.1.65","article-title":"Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study","volume":"120","author":"Litvan","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.amjmed.2004.03.032_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/bmj.310.6977.447","article-title":"Parkinsonism\u2014recognition and differential diagnosis","volume":"310","author":"Quinn","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2004.03.032_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib51","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.410350408","article-title":"Eye movements in parkinsonian syndromes","volume":"35","author":"Vidailhet","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1212\/WNL.53.3.502","article-title":"Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy","volume":"53","author":"Soliveri","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.54.3.697","article-title":"Differentiation of atypical parkinsonian syndromes with routine MRI","volume":"54","author":"Schrag","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archneur.58.7.1076","article-title":"Measurement of the midbrain diameter on routine magnetic resonance imaging","volume":"58","author":"Warmuth-Metz","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2001-13118","article-title":"Diagnosis and management of progressive supranuclear palsy","volume":"21","author":"Litvan","year":"2001","journal-title":"Semin Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","article-title":"Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy","volume":"32","author":"Graham","year":"1969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/1531-8257(200009)15:5<784::AID-MDS1004>3.0.CO;2-P","article-title":"The pathogenesis of multiple system atrophy","volume":"15","author":"Jaros","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2004.03.032_bib58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.1995.00540270090024","article-title":"Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease","volume":"52","author":"Colosimo","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.amjmed.2004.03.032_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/mds.1062","article-title":"Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes","volume":"16","author":"Holmberg","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2004.03.032_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.71.5.596","article-title":"Quantitative anal sphincter EMG in multisystem atrophy and 100 controls","volume":"71","author":"Gilad","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib63","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","article-title":"Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy","volume":"53","author":"Braune","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","article-title":"Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT","volume":"175","author":"Druschky","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.amjmed.2004.03.032_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.65.1.65","article-title":"Clinical usefulness of magnetic resonance imaging in multiple system atrophy","volume":"65","author":"Schrag","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.56.2.225","article-title":"The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences","volume":"56","author":"Kraft","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib67","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/01.WNL.0000032757.66992.3C","article-title":"T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease","volume":"59","author":"Kraft","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/WNL.58.4.575","article-title":"Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD","volume":"58","author":"Schocke","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1531-8249(199901)45:1<65::AID-ART12>3.0.CO;2-1","article-title":"Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy","volume":"45","author":"Schulz","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.73.5.517","article-title":"Differentiating multiple system atrophy from Parkinson's disease","volume":"73","author":"Ghaemi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2004.03.032_bib71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3171\/jns.2003.98.4.0882","article-title":"Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy\u2014parkinsonism. Report of four cases","volume":"8","author":"Visser-Vandewalle","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.amjmed.2004.03.032_bib72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9343(86)90720-5","article-title":"Management of chronic orthostatic hypotension","volume":"80","author":"Onrot","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2004.03.032_bib73","first-page":"9","article-title":"Neuropathologic and molecular considerations","volume":"82","author":"Dickson","year":"2000","journal-title":"Adv Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib74","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","article-title":"Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype","volume":"56","author":"Houlden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2004.03.032_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2001-13119","article-title":"Corticobasal degeneration","volume":"21","author":"Stover","year":"2001","journal-title":"Semin Neurol"},{"key":"10.1016\/j.amjmed.2004.03.032_bib76","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archneur.55.5.609","article-title":"Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration","volume":"55","author":"Yamauchi","year":"1998","journal-title":"Arch Neurol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304003626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304003626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:30:30Z","timestamp":1757579430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934304003626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0002934304003626"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.03.032","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevance","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}